1 Study Coverage 1.1 Mesalamine Product Introduction 1.2 Market by Type 1.2.1 Global Mesalamine Market Size Growth Rate by Type 1.2.2 Purity ≥ 97% 1.2.3 Purity ≥ 98% 1.2.4 Purity ≥ 99% 1.3 Market by Application 1.3.1 Global Mesalamine Market Size Growth Rate by Application 1.3.2 Mesalazine Tablets 1.3.3 Mesalazine Capsules 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Mesalamine Market Size Estimates and Forecasts 2.1.1 Global Mesalamine Revenue 2016-2027 2.1.2 Global Mesalamine Sales 2016-2027 2.2 Mesalamine Market Size by Region: 2021 Versus 2027 2.3 Mesalamine Sales by Region (2016-2027) 2.3.1 Global Mesalamine Sales by Region: 2016-2021 2.3.2 Global Mesalamine Sales Forecast by Region (2022-2027) 2.3.3 Global Mesalamine Sales Market Share by Region (2016-2027) 2.4 Mesalamine Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Mesalamine Revenue by Region: 2016-2021 2.4.2 Global Mesalamine Revenue Forecast by Region (2022-2027) 2.4.3 Global Mesalamine Revenue Market Share by Region (2016-2027) 3 Global Mesalamine by Manufacturers 3.1 Global Top Mesalamine Manufacturers by Sales 3.1.1 Global Mesalamine Sales by Manufacturer (2016-2021) 3.1.2 Global Mesalamine Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Mesalamine Manufacturers by Revenue 3.2.1 Global Mesalamine Revenue by Manufacturer (2016-2021) 3.2.2 Global Mesalamine Revenue Share by Manufacturer (2016-2021) 3.3 Global Mesalamine Price by Manufacturer (2016-2021) 3.4 Competitive Landscape 3.4.1 Key Mesalamine Manufacturers Covered: Ranking by Revenue 3.4.2 Global Mesalamine Market Concentration Ratio (CR5 and HHI) & (2016-2021) 3.4.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.5 Global Mesalamine Manufacturing Base Distribution, Product Type 3.5.1 Mesalamine Manufacturers Manufacturing Base Distribution, Headquarters 3.5.2 Manufacturers Mesalamine Product Type 3.5.3 Date of International Manufacturers Enter into Mesalamine Market 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Company Profiles 4.1 Syntese A/S 4.1.1 Syntese A/S Corporation Information 4.1.2 Syntese A/S Description, Business Overview 4.1.3 Syntese A/S Mesalamine Products Offered 4.1.4 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.1.5 Syntese A/S Mesalamine Revenue by Product 4.1.6 Syntese A/S Mesalamine Revenue by Application 4.1.7 Syntese A/S Mesalamine Revenue by Geographic Area 4.1.8 Syntese A/S Mesalamine Revenue by Sales Channel 4.1.9 Syntese A/S Recent Development 4.2 Divis Laboratories 4.2.1 Divis Laboratories Corporation Information 4.2.2 Divis Laboratories Description, Business Overview 4.2.3 Divis Laboratories Mesalamine Products Offered 4.2.4 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.2.5 Divis Laboratories Mesalamine Revenue by Product 4.2.6 Divis Laboratories Mesalamine Revenue by Application 4.2.7 Divis Laboratories Mesalamine Revenue by Geographic Area 4.2.8 Divis Laboratories Mesalamine Revenue by Sales Channel 4.2.9 Divis Laboratories Recent Development 4.3 Cambrex Corporation 4.3.1 Cambrex Corporation Corporation Information 4.3.2 Cambrex Corporation Description, Business Overview 4.3.3 Cambrex Corporation Mesalamine Products Offered 4.3.4 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.3.5 Cambrex Corporation Mesalamine Revenue by Product 4.3.6 Cambrex Corporation Mesalamine Revenue by Application 4.3.7 Cambrex Corporation Mesalamine Revenue by Geographic Area 4.3.8 Cambrex Corporation Mesalamine Revenue by Sales Channel 4.3.9 Cambrex Corporation Recent Development 4.4 Ipca Laboratories 4.4.1 Ipca Laboratories Corporation Information 4.4.2 Ipca Laboratories Description, Business Overview 4.4.3 Ipca Laboratories Mesalamine Products Offered 4.4.4 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.4.5 Ipca Laboratories Mesalamine Revenue by Product 4.4.6 Ipca Laboratories Mesalamine Revenue by Application 4.4.7 Ipca Laboratories Mesalamine Revenue by Geographic Area 4.4.8 Ipca Laboratories Mesalamine Revenue by Sales Channel 4.4.9 Ipca Laboratories Recent Development 4.5 Hangzhou Brother 4.5.1 Hangzhou Brother Corporation Information 4.5.2 Hangzhou Brother Description, Business Overview 4.5.3 Hangzhou Brother Mesalamine Products Offered 4.5.4 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.5.5 Hangzhou Brother Mesalamine Revenue by Product 4.5.6 Hangzhou Brother Mesalamine Revenue by Application 4.5.7 Hangzhou Brother Mesalamine Revenue by Geographic Area 4.5.8 Hangzhou Brother Mesalamine Revenue by Sales Channel 4.5.9 Hangzhou Brother Recent Development 4.6 PharmaZell 4.6.1 PharmaZell Corporation Information 4.6.2 PharmaZell Description, Business Overview 4.6.3 PharmaZell Mesalamine Products Offered 4.6.4 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.6.5 PharmaZell Mesalamine Revenue by Product 4.6.6 PharmaZell Mesalamine Revenue by Application 4.6.7 PharmaZell Mesalamine Revenue by Geographic Area 4.6.8 PharmaZell Recent Development 4.7 Lianyungang Fengheng Biopharm 4.7.1 Lianyungang Fengheng Biopharm Corporation Information 4.7.2 Lianyungang Fengheng Biopharm Description, Business Overview 4.7.3 Lianyungang Fengheng Biopharm Mesalamine Products Offered 4.7.4 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.7.5 Lianyungang Fengheng Biopharm Mesalamine Revenue by Product 4.7.6 Lianyungang Fengheng Biopharm Mesalamine Revenue by Application 4.7.7 Lianyungang Fengheng Biopharm Mesalamine Revenue by Geographic Area 4.7.8 Lianyungang Fengheng Biopharm Recent Development 4.8 Lasa Loboratory 4.8.1 Lasa Loboratory Corporation Information 4.8.2 Lasa Loboratory Description, Business Overview 4.8.3 Lasa Loboratory Mesalamine Products Offered 4.8.4 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.8.5 Lasa Loboratory Mesalamine Revenue by Product 4.8.6 Lasa Loboratory Mesalamine Revenue by Application 4.8.7 Lasa Loboratory Mesalamine Revenue by Geographic Area 4.8.8 Lasa Loboratory Recent Development 4.9 Erregierre SpA 4.9.1 Erregierre SpA Corporation Information 4.9.2 Erregierre SpA Description, Business Overview 4.9.3 Erregierre SpA Mesalamine Products Offered 4.9.4 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.9.5 Erregierre SpA Mesalamine Revenue by Product 4.9.6 Erregierre SpA Mesalamine Revenue by Application 4.9.7 Erregierre SpA Mesalamine Revenue by Geographic Area 4.9.8 Erregierre SpA Recent Development 4.10 Corden Pharma Bergamo 4.10.1 Corden Pharma Bergamo Corporation Information 4.10.2 Corden Pharma Bergamo Description, Business Overview 4.10.3 Corden Pharma Bergamo Mesalamine Products Offered 4.10.4 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.10.5 Corden Pharma Bergamo Mesalamine Revenue by Product 4.10.6 Corden Pharma Bergamo Mesalamine Revenue by Application 4.10.7 Corden Pharma Bergamo Mesalamine Revenue by Geographic Area 4.10.8 Corden Pharma Bergamo Recent Development 4.11 CTX Lifescience 4.11.1 CTX Lifescience Corporation Information 4.11.2 CTX Lifescience Description, Business Overview 4.11.3 CTX Lifescience Mesalamine Products Offered 4.11.4 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.11.5 CTX Lifescience Mesalamine Revenue by Product 4.11.6 CTX Lifescience Mesalamine Revenue by Application 4.11.7 CTX Lifescience Mesalamine Revenue by Geographic Area 4.11.8 CTX Lifescience Recent Development 4.12 Ishita Active Pharma Ingredients 4.12.1 Ishita Active Pharma Ingredients Corporation Information 4.12.2 Ishita Active Pharma Ingredients Description, Business Overview 4.12.3 Ishita Active Pharma Ingredients Mesalamine Products Offered 4.12.4 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.12.5 Ishita Active Pharma Ingredients Mesalamine Revenue by Product 4.12.6 Ishita Active Pharma Ingredients Mesalamine Revenue by Application 4.12.7 Ishita Active Pharma Ingredients Mesalamine Revenue by Geographic Area 4.12.8 Ishita Active Pharma Ingredients Recent Development 4.13 YC Biotech (Jiangsu) 4.13.1 YC Biotech (Jiangsu) Corporation Information 4.13.2 YC Biotech (Jiangsu) Description, Business Overview 4.13.3 YC Biotech (Jiangsu) Mesalamine Products Offered 4.13.4 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.13.5 YC Biotech (Jiangsu) Mesalamine Revenue by Product 4.13.6 YC Biotech (Jiangsu) Mesalamine Revenue by Application 4.13.7 YC Biotech (Jiangsu) Mesalamine Revenue by Geographic Area 4.13.8 YC Biotech (Jiangsu) Recent Development 4.14 Xinxiang Tianfeng Fine Chemical 4.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information 4.14.2 Xinxiang Tianfeng Fine Chemical Description, Business Overview 4.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Products Offered 4.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2016-2021) 4.14.5 Xinxiang Tianfeng Fine Chemical Mesalamine Revenue by Product 4.14.6 Xinxiang Tianfeng Fine Chemical Mesalamine Revenue by Application 4.14.7 Xinxiang Tianfeng Fine Chemical Mesalamine Revenue by Geographic Area 4.14.8 Xinxiang Tianfeng Fine Chemical Recent Development 5 Breakdown Data by Type 5.1 Global Mesalamine Sales by Type (2016-2027) 5.1.1 Global Mesalamine Sales by Type (2016-2021) 5.1.2 Global Mesalamine Sales Forecast by Type (2022-2027) 5.1.3 Global Mesalamine Sales Market Share by Type (2016-2027) 5.2 Global Mesalamine Revenue Forecast by Type (2016-2027) 5.2.1 Global Mesalamine Revenue by Type (2016-2021) 5.2.2 Global Mesalamine Revenue Forecast by Type (2022-2027) 5.2.3 Global Mesalamine Revenue Market Share by Type (2016-2027) 5.3 Mesalamine Average Selling Price (ASP) by Type (2016-2027) 6 Breakdown Data by Application 6.1 Global Mesalamine Sales by Application (2016-2027) 6.1.1 Global Mesalamine Sales by Application (2016-2021) 6.1.2 Global Mesalamine Sales Forecast by Application (2022-2027) 6.1.3 Global Mesalamine Sales Market Share by Application (2016-2027) 6.2 Global Mesalamine Revenue Forecast by Application (2016-2027) 6.2.1 Global Mesalamine Revenue by Application (2016-2021) 6.2.2 Global Mesalamine Revenue Forecast by Application (2022-2027) 6.2.3 Global Mesalamine Revenue Market Share by Application (2016-2027) 6.3 Mesalamine Average Selling Price (ASP) by Application (2016-2027) 7 North America 7.1 North America Mesalamine Market Size YoY Growth 2016-2027 7.2 North America Mesalamine Market Facts & Figures by Country 7.2.1 North America Mesalamine Sales by Country (2016-2027) 7.2.2 North America Mesalamine Revenue by Country (2016-2027) 7.3 North America Mesalamine Sales by Type 7.4 North America Mesalamine Sales by Application 8 Asia-Pacific 8.1 Asia-Pacific Mesalamine Market Size YoY Growth 2016-2027 8.2 Asia-Pacific Mesalamine Market Facts & Figures by Region 8.2.1 Asia-Pacific Mesalamine Sales by Region (2016-2027) 8.2.2 Asia-Pacific Mesalamine Revenue by Region (2016-2027) 8.3 Asia-Pacific Mesalamine Sales by Type 8.4 Asia-Pacific Mesalamine Sales by Application 9 Europe 9.1 Europe Mesalamine Market Size YoY Growth 2016-2027 9.2 Europe Mesalamine Market Facts & Figures by Country 9.2.1 Europe Mesalamine Sales by Country (2016-2027) 9.2.2 Europe Mesalamine Revenue by Country (2016-2027) 9.3 Europe Mesalamine Sales by Type 9.4 Europe Mesalamine Sales by Application 10 Latin America 10.1 Latin America Mesalamine Market Size YoY Growth 2016-2027 10.2 Latin America Mesalamine Market Facts & Figures by Country 10.2.1 Latin America Mesalamine Sales by Country (2016-2027) 10.2.2 Latin America Mesalamine Revenue by Country (2016-2027) 10.3 Latin America Mesalamine Sales by Type 10.4 Latin America Mesalamine Sales by Application 11 Middle East and Africa 11.1 Middle East and Africa Mesalamine Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Mesalamine Market Facts & Figures by Country 11.2.1 Middle East and Africa Mesalamine Sales by Country (2016-2027) 11.2.2 Middle East and Africa Mesalamine Revenue by Country (2016-2027) 11.3 Middle East and Africa Mesalamine Sales by Type 11.4 Middle East and Africa Mesalamine Sales by Application 12 Supply Chain and Sales Channel Analysis 12.1 Mesalamine Supply Chain Analysis 12.2 Mesalamine Key Raw Materials and Upstream Suppliers 12.3 Mesalamine Clients Analysis 12.4 Mesalamine Sales Channel and Sales Model Analysis 12.4.1 Mesalamine Distribution Channel Analysis: Indirect Sales VS Direct Sales 12.4.2 Mesalamine Distribution Channel Analysis: Online Sales VS Offline Sales 12.4.3 Mesalamine Distributors 13 Market Dynamics 13.1 Mesalamine Market Drivers 13.2 Mesalamine Market Opportunities 13.3 Mesalamine Market Challenges 13.4 Mesalamine Market Restraints 13.5 Porter’s Five Forces Analysis 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Mesalamine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027 Table 2. Major Manufacturers of Purity ≥ 97% Table 3. Major Manufacturers of Purity ≥ 98% Table 4. Major Manufacturers of Purity ≥ 99% Table 5. Global Mesalamine Market Size Growth by Application (US$ Million): 2021 VS 2027 Table 6. Global Mesalamine Market Size by Region (US$ Million): 2021 VS 2027 Table 7. Global Mesalamine Sales by Region (2016-2021) & (MT) Table 8. Global Mesalamine Sales Forecast by Region (2022-2027) & (MT) Table 9. Global Mesalamine Revenue by Region (2016-2021) & (US$ Million) Table 10. Global Mesalamine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 11. Global Mesalamine Sales by Manufacturer (2016-2021) & (MT) Table 12. Global Mesalamine Sales Share by Manufacturer (2016-2021) Table 13. Mesalamine Revenue by Manufacturer (2016-2021) & (US$ Million) Table 14. Mesalamine Revenue Share by Manufacturer (2016-2021) Table 15. Key Manufacturers Mesalamine Price (2016-2021) & (USD/Kg) Table 16. Ranking of Global Top Mesalamine Manufacturers by Revenue (US$ Million) in 2020 Table 17. Global Mesalamine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 18. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mesalamine as of 2020) Table 19. Mesalamine Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Mesalamine Product Type Table 21. Date of International Manufacturers Enter into Mesalamine Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Syntese A/S Corporation Information Table 24. Syntese A/S Description and Business Overview Table 25. Syntese A/S Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 26. Syntese A/S Mesalamine Product Table 27. Syntese A/S Mesalamine Revenue (US$ Million) and Market Share by Product Table 28. Syntese A/S Mesalamine Revenue (US$ Million) and Market Share by Application Table 29. Syntese A/S Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 30. Syntese A/S Mesalamine Revenue (US$ Million) and Market Share by Sales Channel Table 31. Syntese A/S Recent Development Table 32. Divis Laboratories Corporation Information Table 33. Divis Laboratories Description and Business Overview Table 34. Divis Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 35. Divis Laboratories Mesalamine Product Table 36. Divis Laboratories Mesalamine Revenue (US$ Million) and Market Share by Product Table 37. Divis Laboratories Mesalamine Revenue (US$ Million) and Market Share by Application Table 38. Divis Laboratories Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 39. Divis Laboratories Mesalamine Revenue (US$ Million) and Market Share by Sales Channel Table 40. Divis Laboratories Recent Development Table 41. Cambrex Corporation Corporation Information Table 42. Cambrex Corporation Description and Business Overview Table 43. Cambrex Corporation Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 44. Cambrex Corporation Mesalamine Product Table 45. Cambrex Corporation Mesalamine Revenue (US$ Million) and Market Share by Product Table 46. Cambrex Corporation Mesalamine Revenue (US$ Million) and Market Share by Application Table 47. Cambrex Corporation Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 48. Cambrex Corporation Mesalamine Revenue (US$ Million) and Market Share by Sales Channel Table 49. Cambrex Corporation Recent Development Table 50. Ipca Laboratories Corporation Information Table 51. Ipca Laboratories Description and Business Overview Table 52. Ipca Laboratories Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 53. Ipca Laboratories Mesalamine Product Table 54. Ipca Laboratories Mesalamine Revenue (US$ Million) and Market Share by Product Table 55. Ipca Laboratories Mesalamine Revenue (US$ Million) and Market Share by Application Table 56. Ipca Laboratories Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 57. Ipca Laboratories Mesalamine Revenue (US$ Million) and Market Share by Sales Channel Table 58. Ipca Laboratories Recent Development Table 59. Hangzhou Brother Corporation Information Table 60. Hangzhou Brother Description and Business Overview Table 61. Hangzhou Brother Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 62. Hangzhou Brother Mesalamine Product Table 63. Hangzhou Brother Mesalamine Revenue (US$ Million) and Market Share by Product Table 64. Hangzhou Brother Mesalamine Revenue (US$ Million) and Market Share by Application Table 65. Hangzhou Brother Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 66. Hangzhou Brother Mesalamine Revenue (US$ Million) and Market Share by Sales Channel Table 67. Hangzhou Brother Recent Development Table 68. PharmaZell Corporation Information Table 69. PharmaZell Description and Business Overview Table 70. PharmaZell Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 71. PharmaZell Mesalamine Product Table 72. PharmaZell Mesalamine Revenue (US$ Million) and Market Share by Product Table 73. PharmaZell Mesalamine Revenue (US$ Million) and Market Share by Application Table 74. PharmaZell Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 75. PharmaZell Recent Development Table 76. Lianyungang Fengheng Biopharm Corporation Information Table 77. Lianyungang Fengheng Biopharm Description and Business Overview Table 78. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 79. Lianyungang Fengheng Biopharm Mesalamine Product Table 80. Lianyungang Fengheng Biopharm Mesalamine Revenue (US$ Million) and Market Share by Product Table 81. Lianyungang Fengheng Biopharm Mesalamine Revenue (US$ Million) and Market Share by Application Table 82. Lianyungang Fengheng Biopharm Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 83. Lianyungang Fengheng Biopharm Recent Development Table 84. Lasa Loboratory Corporation Information Table 85. Lasa Loboratory Description and Business Overview Table 86. Lasa Loboratory Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 87. Lasa Loboratory Mesalamine Product Table 88. Lasa Loboratory Mesalamine Revenue (US$ Million) and Market Share by Product Table 89. Lasa Loboratory Mesalamine Revenue (US$ Million) and Market Share by Application Table 90. Lasa Loboratory Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 91. Lasa Loboratory Recent Development Table 92. Erregierre SpA Corporation Information Table 93. Erregierre SpA Description and Business Overview Table 94. Erregierre SpA Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 95. Erregierre SpA Mesalamine Product Table 96. Erregierre SpA Mesalamine Revenue (US$ Million) and Market Share by Product Table 97. Erregierre SpA Mesalamine Revenue (US$ Million) and Market Share by Application Table 98. Erregierre SpA Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 99. Erregierre SpA Recent Development Table 100. Corden Pharma Bergamo Corporation Information Table 101. Corden Pharma Bergamo Description and Business Overview Table 102. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 103. Corden Pharma Bergamo Mesalamine Product Table 104. Corden Pharma Bergamo Mesalamine Revenue (US$ Million) and Market Share by Product Table 105. Corden Pharma Bergamo Mesalamine Revenue (US$ Million) and Market Share by Application Table 106. Corden Pharma Bergamo Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 107. Corden Pharma Bergamo Recent Development Table 108. CTX Lifescience Corporation Information Table 109. CTX Lifescience Description and Business Overview Table 110. CTX Lifescience Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 111. CTX Lifescience Mesalamine Product Table 112. CTX Lifescience Mesalamine Revenue (US$ Million) and Market Share by Product Table 113. CTX Lifescience Mesalamine Revenue (US$ Million) and Market Share by Application Table 114. CTX Lifescience Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 115. CTX Lifescience Recent Development Table 116. Ishita Active Pharma Ingredients Corporation Information Table 117. Ishita Active Pharma Ingredients Description and Business Overview Table 118. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 119. Ishita Active Pharma Ingredients Mesalamine Product Table 120. Ishita Active Pharma Ingredients Mesalamine Revenue (US$ Million) and Market Share by Product Table 121. Ishita Active Pharma Ingredients Mesalamine Revenue (US$ Million) and Market Share by Application Table 122. Ishita Active Pharma Ingredients Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 123. Ishita Active Pharma Ingredients Recent Development Table 124. YC Biotech (Jiangsu) Corporation Information Table 125. YC Biotech (Jiangsu) Description and Business Overview Table 126. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 127. YC Biotech (Jiangsu) Mesalamine Product Table 128. YC Biotech (Jiangsu) Mesalamine Revenue (US$ Million) and Market Share by Product Table 129. YC Biotech (Jiangsu) Mesalamine Revenue (US$ Million) and Market Share by Application Table 130. YC Biotech (Jiangsu) Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 131. YC Biotech (Jiangsu) Recent Development Table 132. Xinxiang Tianfeng Fine Chemical Corporation Information Table 133. Xinxiang Tianfeng Fine Chemical Description and Business Overview Table 134. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 135. Xinxiang Tianfeng Fine Chemical Mesalamine Product Table 136. Xinxiang Tianfeng Fine Chemical Mesalamine Revenue (US$ Million) and Market Share by Product Table 137. Xinxiang Tianfeng Fine Chemical Mesalamine Revenue (US$ Million) and Market Share by Application Table 138. Xinxiang Tianfeng Fine Chemical Mesalamine Revenue (US$ Million) and Market Share by Geographic Area Table 139. Xinxiang Tianfeng Fine Chemical Recent Development Table 140. Global Mesalamine Sales by Type (2016-2021) & (MT) Table 141. Global Mesalamine Sales Forecast by Type (2022-2027) & (MT) Table 142. Global Mesalamine Revenue by Type (2016-2021) & (US$ Million) Table 143. Global Mesalamine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 144. Global Mesalamine Sales by Application (2016-2021) & (MT) Table 145. Global Mesalamine Sales Forecast by Application (2022-2027) & (MT) Table 146. Global Mesalamine Revenue by Application (2016-2021) & (US$ Million) Table 147. Global Mesalamine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 148. North America Mesalamine Sales by Country (2016-2021) & (MT) Table 149. North America Mesalamine Sales by Country (2022-2027) & (MT) Table 150. North America Mesalamine Revenue by Country (2016-2021) & (US$ Million) Table 151. North America Mesalamine Revenue by Country (2022-2027) & (US$ Million) Table 152. North America Mesalamine Sales by Type (2016-2021) & (MT) Table 153. North America Mesalamine Sales by Application (2016-2021) & (MT) Table 154. Asia-Pacific Mesalamine Sales by Region (2016-2021) & (MT) Table 155. Asia-Pacific Mesalamine Sales by Region (2022-2027) & (MT) Table 156. Asia-Pacific Mesalamine Revenue by Region (2016-2027) & (US$ Million) Table 157. Asia-Pacific Mesalamine Revenue by Region (2022-2027) & (US$ Million) Table 158. Asia-Pacific Mesalamine Sales by Type (2016-2021) & (MT) Table 159. Asia-Pacific Mesalamine Sales by Application (2016-2021) & (MT) Table 160. Europe Mesalamine Sales by Country (2016-2021) & (MT) Table 161. Europe Mesalamine Sales by Country (2022-2027) & (MT) Table 162. Europe Mesalamine Revenue by Country (2016-2021) & (US$ Million) Table 163. Europe Mesalamine Revenue by Country (2022-2027) & (US$ Million) Table 164. Europe Mesalamine Sales by Type (2016-2021) & (MT) Table 165. Europe Mesalamine Sales by Application (2016-2021) & (MT) Table 166. Latin America Mesalamine Sales by Country (2016-2021) & (MT) Table 167. Latin America Mesalamine Sales by Country (2022-2027) & (MT) Table 168. Latin America Mesalamine Revenue by Country (2016-2021) & (US$ Million) Table 169. Latin America Mesalamine Revenue by Country (2022-2027) & (US$ Million) Table 170. Latin America Mesalamine Sales by Type (2016-2021) & (MT) Table 171. Latin America Mesalamine Sales by Application (2016-2021) & (MT) Table 172. Middle East and Africa Mesalamine Sales by Country (2016-2021) & (MT) Table 173. Middle East and Africa Mesalamine Sales by Country (2022-2027) & (MT) Table 174. Middle East and Africa Mesalamine Revenue by Country (2016-2021) & (US$ Million) Table 175. Middle East and Africa Mesalamine Revenue by Country (2022-2027) & (US$ Million) Table 176. Middle East and Africa Mesalamine Sales by Type (2016-2021) & (MT) Table 177. Middle East and Africa Mesalamine Sales by Application (2016-2021) & (MT) Table 178. Mesalamine Key Raw Materials, Industry Status and Trend Table 179. Mesalamine Key Raw Materials and Upstream Suppliers Table 180. Mesalamine Clients Status and Trend Table 181. Mesalamine Typical Clients Table 182. Mesalamine Distributors Table 183. Key Drivers: Impact Analysis (2022-2027) Table 184. Mesalamine Market Drivers Table 185. Mesalamine Market Opportunities Table 186. Mesalamine Market Challenges Table 187. Mesalamine Market Restraints Table 188. Mesalamine Porter’s Five Forces Analysis Table 189. Research Programs/Design for This Report Table 190. Key Data Information from Secondary Sources Table 191. Key Data Information from Primary Sources List of Figures Figure 1. Mesalamine Product Picture Figure 2. Global Mesalamine Sales Market Share by Type in 2021 & 2027 Figure 3. Purity ≥ 97% Product Picture Figure 4. Purity ≥ 98% Product Picture Figure 5. Purity ≥ 99% Product Picture Figure 6. Global Mesalamine Sales Market Share by Application in 2021 & 2027 Figure 7. Mesalazine Tablets Examples Figure 8. Mesalazine Capsules Examples Figure 9. Others Examples Figure 10. Mesalamine Report Years Considered Figure 11. Global Mesalamine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Mesalamine Market Size 2016-2027 (US$ Million) Figure 13. Global Mesalamine Sales 2016-2027 (K Units) Figure 14. Global Mesalamine Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Mesalamine Sales Market Share Forecast by Region (2016-2027) Figure 16. Global Mesalamine Revenue Market Share by Region (2016-2027) Figure 17. Global Mesalamine Sales Share by Manufacturer in 2020 Figure 18. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Mesalamine Sales Market Share Forecast by Type (2016-2027) Figure 20. Global Mesalamine Revenue Market Share Forecast by Type (2016-2027) Figure 21. Mesalamine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Figure 22. Global Mesalamine Sales Market Share Forecast by Application (2016-2027) Figure 23. Global Mesalamine Revenue Market Share Forecast by Application (2016-2027) Figure 24. Mesalamine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Figure 25. North America Mesalamine Revenue 2016-2027 (US$ Million) Figure 26. North America Mesalamine Sales Market Share by Type (2016-2021) Figure 27. North America Mesalamine Sales Market Share by Application (2016-2021) Figure 28. Asia-Pacific Mesalamine Revenue 2016-2027 (US$ Million) Figure 29. Asia-Pacific Mesalamine Sales Market Share by Region (2016-2027) Figure 30. Asia-Pacific Mesalamine Revenue Market Share by Region (2016-2027) Figure 31. Asia-Pacific Mesalamine Sales Market Share by Type (2016-2021) Figure 32. Asia-Pacific Mesalamine Sales Market Share by Application (2016-2021) Figure 33. Europe Mesalamine Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. Europe Mesalamine Sales Market Share by Country (2016-2027) Figure 35. Europe Mesalamine Revenue Market Share by Country (2016-2027) Figure 36. Europe Mesalamine Sales Market Share by Type (2016-2021) Figure 37. Europe Mesalamine Sales Market Share by Application (2016-2021) Figure 38. Latin America Mesalamine Revenue Growth Rate 2016-2027 (US$ Million) Figure 39. Latin America Mesalamine Sales Market Share by Country (2016-2027) Figure 40. Latin America Mesalamine Revenue Market Share by Country (2016-2021) Figure 41. Latin America Mesalamine Sales Market Share by Type (2016-2021) Figure 42. Latin America Mesalamine Sales Market Share by Application (2016-2021) Figure 43. Middle East and Africa Mesalamine Revenue Growth Rate 2016-2027 (US$ Million) Figure 44. Middle East and Africa Mesalamine Sales Market Share by Country (2016-2027) Figure 45. Middle East and Africa Mesalamine Revenue Market Share by Country (2016-2027) Figure 46. Middle East and Africa Mesalamine Sales Market Share by Type (2016-2021) Figure 47. Middle East and Africa Mesalamine Sales Market Share by Application (2016-2021) Figure 48. Mesalamine Supply Chain (Upstream and Downstream Market) Figure 49. Global Production Market Share of Mesalamine Raw Materials by Region in 2020 Figure 50. Mesalamine Distribution Channels Figure 51. Global Mesalamine Percentage 2016-2027: Indirect Sales VS Direct Sales Figure 52. Global Mesalamine Percentage 2016-2027: Online Sales VS Offline Sales Figure 53. Porter's Five Forces Analysis Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Syntese A/S Divis Laboratories Cambrex Corporation Ipca Laboratories Hangzhou Brother PharmaZell Lianyungang Fengheng Biopharm Lasa Loboratory Erregierre SpA Corden Pharma Bergamo CTX Lifescience Ishita Active Pharma Ingredients YC Biotech (Jiangsu) Xinxiang Tianfeng Fine Chemical